HumProTher Laboratory, TheREx, TIMC-IMAG Laboratory, CNRS UMR5525, University Joseph Fourier, La Tronche, France.
PLoS One. 2012;7(9):e45416. doi: 10.1371/journal.pone.0045416. Epub 2012 Sep 27.
Protein transduction offers a great therapeutic potential by efficient delivery of biologically active cargo into cells. The Adenovirus Dd (Dodecahedron) has recently been shown to deliver proteins fused to the tandem WW(2-3-4) structural domains from the E3 ubiquitin ligase Nedd4. In this study, we conclusively show that Dd is able to efficiently deliver cargo inside living cells, which mainly localize in fast moving endocytic vesicles, supporting active transport along the cytoskeleton. We further improve this delivery system by expressing a panel of 13 WW-GFP mutant forms to characterize their binding properties towards Dd. We identified the domain WW(3) and its mutant form WW(3)_10_13 to be sufficient for optimal binding to Dd. We greatly minimise the interacting WW modules from 20 to 6 kDa without compromising its efficient delivery by Dd. Using these minimal WW domains fused to the tumor suppressor p53 protein, we show efficient cellular uptake and distribution into cancer cells, leading to specific induction of apoptosis in these cells. Taken together, these findings represent a step further towards the development of a Dd-based delivery system for future therapeutic application.
蛋白转导通过将生物活性货物高效递送到细胞内,提供了巨大的治疗潜力。最近已经表明,腺病毒 Dd(十二面体)能够将融合了 E3 泛素连接酶 Nedd4 的串联 WW(2-3-4)结构域的蛋白质递送到细胞内。在这项研究中,我们明确表明 Dd 能够有效地将货物递送到活细胞内,这些货物主要定位于快速移动的内吞小泡中,支持沿着细胞骨架的主动运输。我们通过表达一系列 13 种 WW-GFP 突变体来进一步改进这个递药系统,以研究它们与 Dd 的结合特性。我们发现 WW(3)结构域及其突变体 WW(3)10-13 对于与 Dd 的最佳结合是足够的。我们将相互作用的 WW 模块从 20 kDa 大大减小到 6 kDa,而不会影响 Dd 的有效递药。我们使用这些最小的 WW 结构域融合肿瘤抑制蛋白 p53,证明了其在癌细胞中的有效摄取和分布,导致这些细胞中特定的细胞凋亡诱导。总之,这些发现代表了朝着开发基于 Dd 的递药系统以用于未来治疗应用迈出的一步。